/

Società

B.

Non verificato

B.More Inc.

Di cosa scriviamo

BiologyPharmaceuticalsSanità

2 comunicati stampa

Guarda tutti i comunicati

Press Release cover image

31/10/2024

Pharmaceuticals

Sanità

Biology

B.More Collaborator, Dr. Michael Bogenschutz, Awarded $15 Million NIDA Grant for Landmark Psilocybin Study in Opioid Use Disorder

Fonte

Emittente

1,00

0

Press Release cover image

12/09/2024

Pharmaceuticals

Sanità

Biology

B.More Collaborator, Dr. Michael Bogenschutz, Awarded NIAAA Grant for Psilocybin in Alcohol Use Disorder Trial at NYU and Silver Hill Hospital

Fonte

Emittente

1,00

0

Seguaci

0

Compatibilità

0